495 related articles for article (PubMed ID: 16170190)
21. Metastatic renal cell carcinoma: systemic treatment.
Abi-Aad AS; deKernion JB
Acta Urol Belg; 1996 May; 64(2):3-8. PubMed ID: 8701805
[No Abstract] [Full Text] [Related]
22. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
23. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
Pandha H
Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872
[No Abstract] [Full Text] [Related]
24. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
25. The role of radical nephrectomy in metastatic renal cell carcinoma.
Flanigan RC; Yonover PM
Semin Urol Oncol; 2001 May; 19(2):98-102. PubMed ID: 11354539
[TBL] [Abstract][Full Text] [Related]
26. Advances in immune-based therapies of renal cell carcinoma.
Lam JS; Belldegrun AS; Figlin RA
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1081-96. PubMed ID: 15606335
[TBL] [Abstract][Full Text] [Related]
27. Editorial comment on: Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysis.
Bamias A
Eur Urol; 2009 Jun; 55(6):1439. PubMed ID: 18950935
[No Abstract] [Full Text] [Related]
28. [First-line therapy for German patients with metastatic kidney neoplasms in EORTC-Protocol 30012].
Rexer H
Urologe A; 2004 Aug; 43(8):992-3. PubMed ID: 15316609
[No Abstract] [Full Text] [Related]
29. Prognostic factors in renal cell cancer.
Park WH; Eisen T
BJU Int; 2007 May; 99(5 Pt B):1277-81. PubMed ID: 17441924
[No Abstract] [Full Text] [Related]
30. Debulking nephrectomy in metastatic renal cancer.
Flanigan RC
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6335S-41S. PubMed ID: 15448027
[TBL] [Abstract][Full Text] [Related]
31. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
33. Vaccine therapy in patients with renal cell carcinoma.
Van Poppel H; Joniau S; Van Gool SW
Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
[TBL] [Abstract][Full Text] [Related]
34. Ablative techniques for the management of kidney cancer.
Hafron J; Kaouk JH
Nat Clin Pract Urol; 2007 May; 4(5):261-9. PubMed ID: 17483811
[TBL] [Abstract][Full Text] [Related]
35. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
Liu Z; Lv J; Ding K; Fu Q; Cao Q; Wang F
Int J Urol; 2009 Mar; 16(3):268-73. PubMed ID: 19087209
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
37. Cytokine therapy response as a selection criterion for cytoreductive nephrectomy in metastatic renal clear-cell carcinoma of intermediate prognosis. Results and conclusions from a combined analysis.
Bex A; Haanen JB; Vyth-Dreese FA; Horenblas S; de Gast GC
Urol Int; 2008; 80(4):367-71. PubMed ID: 18587246
[TBL] [Abstract][Full Text] [Related]
38. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
[TBL] [Abstract][Full Text] [Related]
39. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
Healy KA; Marshall FF; Ogan K
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1295-304. PubMed ID: 16925495
[TBL] [Abstract][Full Text] [Related]
40. Presurgical therapy in metastatic renal cell carcinoma.
Jonasch E
Expert Rev Anticancer Ther; 2007 Jan; 7(1):73-8. PubMed ID: 17187521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]